MARKET

OPK

OPK

Opko Health
NASDAQ
1.490
-0.010
-0.67%
After Hours: 1.470 -0.02 -1.34% 19:20 07/07 EDT
OPEN
1.490
PREV CLOSE
1.500
HIGH
1.510
LOW
1.460
VOLUME
2.13M
TURNOVER
--
52 WEEK HIGH
1.605
52 WEEK LOW
0.9769
MARKET CAP
1.13B
P/E (TTM)
-5.4419
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at OPK last week (0629-0703)?
Weekly Report · 1d ago
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 5d ago
OPKO Health (OPK) Ownership Update Draws Attention, Is The 55% Undervalued View Convincing?
Simply Wall St · 5d ago
Weekly Report: what happened at OPK last week (0622-0626)?
Weekly Report · 06/29 10:21
OPKO Health (OPK) Stock Could Be 57% Undervalued As Margin Recovery Comes Into Focus
Simply Wall St · 06/24 00:36
Weekly Report: what happened at OPK last week (0615-0619)?
Weekly Report · 06/22 10:31
Opko Health Shareholders Back Board, Equity and Auditors
TipRanks · 06/18 20:57
Opko Health shareholders approve 2026 equity incentive plan at annual meeting
PUBT · 06/18 20:07
More
About OPK
OPKO Health, Inc. is a multinational biopharmaceutical and diagnostics company. The Company’s segments include pharmaceutical and diagnostics. The pharmaceutical segment consists of the pharmaceutical operations it operates in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its global pharmaceutical research and development operations. The diagnostics segment primarily consists of clinical laboratory operations through BioReference and its point-of-care operations. Its pharmaceutical business features Somatrogon (hGH-CTP), a once-weekly human growth hormone injection, and it is marketed under the brand name NGENLA. The Company, through its pharmaceutical division, manufactures and sells Rayaldee, a United States Food and Drug Administration (FDA) approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency.

Webull offers OPKO Health Inc stock information, including NASDAQ: OPK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OPK stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OPK stock methods without spending real money on the virtual paper trading platform.